Conversion to Everolimus in Kidney Transplant Recipients: A Safe and Simple Procedure

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2424-2426

  Ruiz, J C ^a   Sanchez Fructuoso, A ^b   Rodrigo, E ^a   Conesa, J ^b   Cotorruelo, J G ^a   Gomez Alamillo C ^a   Calvo, N ^b   Barrientos, A ^b   Arias, M ^a  

^a HU Valdecilla   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RAPAMYCIN; TSUKUBAENOLIDE;

ARTICLE; CANCER; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG TARGETING; DRUG WITHDRAWAL; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; LEG EDEMA; MOUTH ULCER; PRIORITY JOURNAL; SUSPENSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR DISEASE;

CALCINEURIN; CREATININE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; SIROLIMUS; TREATMENT OUTCOME;

EID: 33750633495     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.190     Document Type: Article

References (7)

1. Bumbea V., Kamar N., Ribes D., et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 20 (2005) 2517
2. Wu M.S., Chang C.T., and Hung C.C. Rapamycin in patients with chronic renal allograft dysfunction. Clin Transplant 19 (2005) 236
3. Diekmann F., Budde K., Oppenheimer F., et al. Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction. Am J Transplant 4 (2004) 1869
4. Letavernier E., Pe'raldi M.N., Pariente A., et al. Proteinuria following a switch from calcineurin inhibitors to sirolimus. Transplantation 80 (2005) 1198
5. Ruiz J.C., Diekmann F., Campistol J.M., et al. Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study. Transplant Proc 37 (2005) 3833
6. Nashan B., Curtis J., Ponticelli C., et al. Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study. Transplantation 78 (2004) 1332
7. Pascual J. Concentration-controlled everolimus (Certican): combination with reduced dose calcineurin inhibitors. Transplantation 79 suppl (2005) S76